Skip to main content
. 2024 Dec 2;82:231. doi: 10.1186/s13690-024-01459-2
Text box 1. Contributions to the literature
• The effectiveness of the use of continuous glucose monitoring (CGM) devices for management of type 2 diabetes mellitus (T2DM) has been evaluated in a number of ways across multiple studies, but the totality of the evidence has not been consolidated into a single review.
• CGM is better than self-monitoring of blood glucose or usual care in reducing glycated hemoglobin levels and increasing time-in-range but no significant differences were found in patient-reported outcome measure changes.
• CGM is a promising alternative for T2DM management, although more studies on patient usability and experience is needed.